Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hospitals, Public | 2 | 2019 | 64 | 0.730 |
Why?
|
| Safety-net Providers | 1 | 2019 | 53 | 0.680 |
Why?
|
| Health Services Research | 1 | 2019 | 233 | 0.610 |
Why?
|
| Tuberculosis, Miliary | 1 | 2015 | 12 | 0.520 |
Why?
|
| Tuberculosis, Pleural | 1 | 2015 | 11 | 0.520 |
Why?
|
| PubMed | 1 | 2015 | 41 | 0.520 |
Why?
|
| Antimalarials | 2 | 2012 | 55 | 0.480 |
Why?
|
| Health Status Indicators | 1 | 2014 | 224 | 0.450 |
Why?
|
| Malaria | 1 | 2012 | 92 | 0.410 |
Why?
|
| Brain Diseases | 3 | 2006 | 403 | 0.400 |
Why?
|
| Emigration and Immigration | 4 | 2007 | 86 | 0.380 |
Why?
|
| Peripheral Nervous System | 1 | 2010 | 42 | 0.370 |
Why?
|
| Informed Consent | 1 | 2013 | 419 | 0.370 |
Why?
|
| Neurocysticercosis | 2 | 2006 | 33 | 0.350 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2010 | 317 | 0.310 |
Why?
|
| Central Nervous System | 1 | 2010 | 436 | 0.310 |
Why?
|
| Antitubercular Agents | 1 | 2010 | 318 | 0.310 |
Why?
|
| Developing Countries | 1 | 2010 | 315 | 0.300 |
Why?
|
| Uncompensated Care | 1 | 2007 | 11 | 0.300 |
Why?
|
| HIV Infections | 4 | 2010 | 2134 | 0.300 |
Why?
|
| HIV-1 | 2 | 2010 | 653 | 0.280 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 500 | 0.270 |
Why?
|
| Malaria, Cerebral | 1 | 2003 | 4 | 0.240 |
Why?
|
| Tuberculosis | 1 | 2010 | 548 | 0.240 |
Why?
|
| Cysticercosis | 2 | 1994 | 31 | 0.230 |
Why?
|
| Malaria, Falciparum | 1 | 2003 | 46 | 0.230 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 1225 | 0.220 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1997 | 362 | 0.210 |
Why?
|
| Psychotic Disorders | 1 | 2003 | 147 | 0.200 |
Why?
|
| Health Care Costs | 1 | 2007 | 674 | 0.200 |
Why?
|
| HIV Seroprevalence | 1 | 1999 | 11 | 0.180 |
Why?
|
| Private Sector | 1 | 2019 | 32 | 0.180 |
Why?
|
| Birth Rate | 1 | 2019 | 17 | 0.180 |
Why?
|
| Cities | 1 | 2019 | 49 | 0.170 |
Why?
|
| Utilization Review | 1 | 1999 | 48 | 0.170 |
Why?
|
| Geography | 1 | 2019 | 140 | 0.170 |
Why?
|
| Liver Abscess, Amebic | 1 | 1998 | 3 | 0.170 |
Why?
|
| Blood Donors | 1 | 1999 | 164 | 0.170 |
Why?
|
| Kidney Failure, Chronic | 1 | 2007 | 960 | 0.170 |
Why?
|
| Infant Mortality | 1 | 2019 | 186 | 0.160 |
Why?
|
| Community Health Services | 1 | 1999 | 126 | 0.160 |
Why?
|
| Texas | 8 | 2012 | 6311 | 0.150 |
Why?
|
| Global Health | 2 | 2014 | 657 | 0.150 |
Why?
|
| Mortality | 1 | 2019 | 343 | 0.150 |
Why?
|
| Public Health | 1 | 2019 | 299 | 0.140 |
Why?
|
| Data Collection | 1 | 2019 | 620 | 0.140 |
Why?
|
| Regression Analysis | 2 | 2019 | 1546 | 0.140 |
Why?
|
| Topography, Medical | 1 | 2014 | 6 | 0.130 |
Why?
|
| Delivery of Health Care | 2 | 2019 | 860 | 0.130 |
Why?
|
| Cross-Cultural Comparison | 1 | 2013 | 87 | 0.110 |
Why?
|
| Population Surveillance | 2 | 2012 | 627 | 0.110 |
Why?
|
| Travel | 2 | 2012 | 190 | 0.110 |
Why?
|
| Quality of Life | 1 | 2007 | 4532 | 0.110 |
Why?
|
| Anti-Retroviral Agents | 1 | 2014 | 148 | 0.110 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2014 | 113 | 0.110 |
Why?
|
| Humans | 22 | 2019 | 261506 | 0.110 |
Why?
|
| Europe | 1 | 2014 | 649 | 0.110 |
Why?
|
| Terminology as Topic | 1 | 2015 | 414 | 0.110 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 4298 | 0.100 |
Why?
|
| Central America | 3 | 2005 | 29 | 0.100 |
Why?
|
| Cluster Analysis | 1 | 2013 | 1053 | 0.100 |
Why?
|
| Child Day Care Centers | 1 | 1990 | 24 | 0.100 |
Why?
|
| Giardiasis | 1 | 1990 | 15 | 0.100 |
Why?
|
| Infant | 2 | 2019 | 13310 | 0.090 |
Why?
|
| Seizures | 2 | 1994 | 989 | 0.090 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2014 | 393 | 0.090 |
Why?
|
| Disease Outbreaks | 2 | 1990 | 415 | 0.090 |
Why?
|
| United States | 2 | 2019 | 15433 | 0.090 |
Why?
|
| Sarcoma, Kaposi | 1 | 1990 | 187 | 0.080 |
Why?
|
| Physician-Patient Relations | 1 | 2013 | 792 | 0.080 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2010 | 426 | 0.080 |
Why?
|
| Cytomegalovirus | 1 | 1990 | 482 | 0.070 |
Why?
|
| Mental Disorders | 1 | 2014 | 862 | 0.070 |
Why?
|
| Mefloquine | 1 | 2003 | 10 | 0.060 |
Why?
|
| Male | 10 | 2012 | 123000 | 0.060 |
Why?
|
| Female | 10 | 2012 | 141928 | 0.060 |
Why?
|
| Plasmodium falciparum | 1 | 2003 | 65 | 0.060 |
Why?
|
| Middle Aged | 8 | 2012 | 86204 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 945 | 0.060 |
Why?
|
| Adult | 8 | 2012 | 77950 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2015 | 9244 | 0.050 |
Why?
|
| Emergency Medical Services | 1 | 2007 | 429 | 0.050 |
Why?
|
| Syndrome | 1 | 2003 | 1351 | 0.050 |
Why?
|
| HIV-2 | 1 | 1999 | 10 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2007 | 945 | 0.040 |
Why?
|
| Africa | 1 | 1999 | 142 | 0.040 |
Why?
|
| Adolescent | 4 | 2012 | 31252 | 0.040 |
Why?
|
| El Salvador | 1 | 1997 | 4 | 0.040 |
Why?
|
| Honduras | 1 | 1997 | 21 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 1998 | 120 | 0.040 |
Why?
|
| Animals | 6 | 2010 | 59536 | 0.040 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1997 | 42 | 0.040 |
Why?
|
| Hospitals, Urban | 1 | 1997 | 87 | 0.040 |
Why?
|
| Homosexuality, Male | 1 | 1997 | 71 | 0.040 |
Why?
|
| Child | 4 | 2012 | 29154 | 0.040 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1997 | 297 | 0.040 |
Why?
|
| Aged | 3 | 2012 | 70117 | 0.040 |
Why?
|
| Health Services Needs and Demand | 1 | 1999 | 244 | 0.040 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1997 | 163 | 0.040 |
Why?
|
| Tuberculosis, Meningeal | 1 | 1996 | 30 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2012 | 16273 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2007 | 37905 | 0.030 |
Why?
|
| Sexual Behavior | 1 | 1997 | 310 | 0.030 |
Why?
|
| Taenia | 1 | 1994 | 13 | 0.030 |
Why?
|
| Praziquantel | 1 | 1994 | 15 | 0.030 |
Why?
|
| Odds Ratio | 1 | 1999 | 2316 | 0.030 |
Why?
|
| Young Adult | 1 | 2012 | 21445 | 0.030 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2014 | 182 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2007 | 12873 | 0.030 |
Why?
|
| USSR | 1 | 1990 | 6 | 0.020 |
Why?
|
| Risk Factors | 3 | 2005 | 17523 | 0.020 |
Why?
|
| Homosexuality | 1 | 1990 | 32 | 0.020 |
Why?
|
| Zidovudine | 1 | 1990 | 40 | 0.020 |
Why?
|
| Prevalence | 1 | 1997 | 3260 | 0.020 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1990 | 68 | 0.020 |
Why?
|
| Pregnancy | 1 | 1999 | 7573 | 0.020 |
Why?
|
| Cytomegalovirus Infections | 1 | 1990 | 462 | 0.020 |
Why?
|
| Animal Husbandry | 1 | 2005 | 42 | 0.020 |
Why?
|
| Mexico | 1 | 2005 | 259 | 0.020 |
Why?
|
| Meat Products | 1 | 1984 | 6 | 0.020 |
Why?
|
| Typhoid Fever | 1 | 1984 | 16 | 0.020 |
Why?
|
| Food Microbiology | 1 | 1984 | 26 | 0.020 |
Why?
|
| Meat | 1 | 1984 | 87 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 3719 | 0.010 |
Why?
|
| Mexican Americans | 1 | 2005 | 322 | 0.010 |
Why?
|
| Swine | 1 | 2005 | 1541 | 0.010 |
Why?
|
| Hospitals, Municipal | 1 | 1996 | 3 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2014 | 32848 | 0.010 |
Why?
|
| Prognosis | 1 | 1992 | 21713 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1996 | 2307 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1996 | 4744 | 0.000 |
Why?
|
| Incidence | 1 | 1996 | 5673 | 0.000 |
Why?
|
| Survival Analysis | 1 | 1996 | 9180 | 0.000 |
Why?
|
| Salmonella typhi | 1 | 1984 | 15 | 0.000 |
Why?
|
| Cattle | 1 | 1984 | 783 | 0.000 |
Why?
|
| Feces | 1 | 1984 | 770 | 0.000 |
Why?
|